Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23 in JAMA ...
Treatment depends on the cause and ... and asthma (which affects the airways in the lungs). Atopic dermatitis is a type of chronic eczema. It's more common in infants and children, as well as ...
Evommune, Inc., a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the completion of a $115 million Series C ...